dehydrocrotonin has been researched along with Liver Neoplasms in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Borges, RDS; Calandrini de Azevedo, LF; Melo Lima, KM; Nagamachi, CY; Panarra Ferreira Gomes das Neves, PA; Pieczarka, JC; Silva de Carvalho, V | 1 |
1 other study(ies) available for dehydrocrotonin and Liver Neoplasms
| Article | Year |
|---|---|
New derivative of trans-dehydrocrotonin isolated from Croton cajucara shows reduced cytotoxic and genotoxic effects in hepatocellular carcinoma (HepG2) cell line.
Topics: Antineoplastic Agents; Carcinoma, Hepatocellular; Cell Line; Croton; DNA Damage; Hep G2 Cells; Humans; Liver Neoplasms | 2022 |